At EBITDA-C, which is the financial metric we follow most closely internally. So growth and EBITDA are what we're looking at. We see that almost all of those 11 million NOK translate to an improved EBITDA, showing an improvement of 10 million NOK. And looking at this chart here, we have made some changes. So now we have moved HPI and Ad Opus into operations. They were previously in a separate lane together with Confrere. As we saw, we had to make a lot of improvements. So Confrere has now been divested, and HPI and Ad Opus are no longer losing large amounts of money. So now, looking at operations as such, it does not mean that we do not still need to continue to improve in that area, but we need to improve in all areas, so it doesn’t make them unique in any sense anymore. You see the growth of 17%. You see that operations have improved their EBITDA from 11 million to 18 million in the quarter, and EBITDA from 5 to 13 million. Webdoc X now incurs a running cost of 4 million each quarter. That's roughly where it will be. We're not aiming to go lower. This is where the running rate will be. We have a really efficient team making significant improvements in the development. We said it's been very stable now. We have made a lot of changes to that part of the organization and removed many consultants. We are quite happy with where that project stands at the moment. We are also lowering costs somewhat at the HQ level. I receive many questions about the situation with Millennium. So I thought it was worth discussing a bit about the potential consequences of that situation during this call. The background is that the Triathlon Union, having decided many years ago, mandated that when they switched to Millennium as their EHR system for public ARR, all private providers offering public care should also transition to the same system. And they do this to ensure that information can flow between systems. That can be accomplished in many other ways too. You can use APIs, and you can use robots. You can use the national services that are used to exchange information in Sweden, known as MPL. Most users know it as T2. So there are many other ways of accomplishing most of what they want to accomplish. All the caregivers really want to avoid transitioning to Millennium. It's a very outdated system. It fits them very poorly, and it is significantly more expensive than their current system. The price is not the major hurdle. The major hurdle is that it would significantly disrupt their operations and financial stability. It would really, really hurt them financially, and their operations would become much less efficient. Uh, where we are at is that according to the region, the first private primary care clinics should move into Millennium by the end of next year. Um, that will most likely be delayed again, but that's where they are at the moment. And that will just be a few clinics. Um, and looking at the potential outcomes, now that the private providers are trying not to get in there, we are supporting them heavily. There will be legal processes. There was quite a good case. It was a very strong case. I think it's more likely than not that they will succeed. But you never know with those types of cases. It might also become obvious, and quite likely, apparent to the region. This is not a good idea. It's really difficult for them to be a good provider to the private providers of electronic health record systems. So, the potential and the range of outcomes is what I wanted to show you. So if the region were to succeed and actually manage to resolve the legal cases, suppress all the complaints from private providers, and successfully roll it out, then it would result in a one-time churn of 15 to 25 million SEK. Um, the reason it's a range is because we cannot see what our customers are using Webdoc X for. We're not allowed to enter and see the type of patients they have, and they are only permitted to use Millennium for the patients, provided they are public patients. So, not occupational health, not insurance, not private pay patients, and so on, not vaccinations. Many might have to use double systems. That's why we have a range of scenarios from worst case to best case, and usage would be unaffected. We are not able to sell to customers at this moment who are expected to eventually transition to using Millennium. They are not purchasing a new EHR system at the moment. Then if the provider succeeds and stops this, then we would have zero chance and we would see a big increase in new sales, because at the moment we cannot sell to the region where we are the largest and most well known. So, in this scenario, we would see a big increase in new sales. And then there's the middle ground. As I said previously, many might have to use double systems. Millennium is a really bad system for our customers, so they might want to stay in Webdoc X, and then we'll transfer data into Millennium, as we do in Stockholm, where we now have the referrals going back and forth between the public system there, without the region actually opening up anything for us, we just solved it at our end, and then users would likely increase in this middle ground because then they know that they can use Webdoc X for certain patients. So these are the scenarios that we could end up in. I think it's more like not that we will succeed. And then we have a big positive scenario. In the worst case, we have roughly one year's growth that, in the worst case scenario, we would lose. The last update from June was very positive, indicating that private specialists will be excluded. They do not have to use Millennium anymore. So looking ahead, going forward, we see a really big interest in surgery. We have been developing that for quite some time now, and it will go live early next year. We can therefore start selling it now. And we're aiming to sign multiple contracts in the coming months. We believe that we have a very strong offering and have received a very positive response from potential customers. We will continue to work with efficiency; if we get a couple of percentage points more efficient in all parts every month, over a year, that translates to big improvements. And over two years, it's even bigger improvements, and we can do a lot to become more efficient. Um, I mean, most of the organization is new, either from a structural point of view or from the people, or both. So that means that there's still a lot to get in place and to become really, really efficient in all parts. And that's something we're working hard at. Um, an important area for us is cost control in this line of work.